BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 410296)

  • 21. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
    Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
    Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
    Gandhi AK; Sharma DN; Rath GK; Julka PK; Subramani V; Sharma S; Manigandan D; Laviraj MA; Kumar S; Thulkar S
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):542-8. PubMed ID: 24074927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cancer of the uterine cervix: combination of radiotherapy and cisplatin chemotherapy (chemoradiotherapy) is superior to radiotherapy alone in local advanced stages].
    Mazeron JJ
    Bull Cancer; 1999 Mar; 86(3):247-8. PubMed ID: 10847719
    [No Abstract]   [Full Text] [Related]  

  • 24. Carcinoma of the cervix treated with chemotherapy and radiation therapy. Cooperative studies in the Gynecologic Oncology Group.
    Stehman FB; Bundy BN
    Cancer; 1993 Feb; 71(4 Suppl):1697-701. PubMed ID: 8431908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study.
    Muderspach LI; Curtin JP; Roman LD; Gebhardt JA; Klement V; Qian D; Morrow CP; Felix JC; Formenti SC; Muggia FM
    Gynecol Oncol; 1997 May; 65(2):336-42. PubMed ID: 9159348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer.
    Okada M; Kigawa J; Minagawa Y; Kanamori Y; Shimada M; Takahashi M; Oishi T; Terakawa N
    Gynecol Oncol; 1998 Jul; 70(1):61-4. PubMed ID: 9698475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
    Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
    Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial.
    Stehman FB; Bundy BN; Thomas G; Keys HM; d'Ablaing G; Fowler WC; Mortel R; Creasman WT
    J Clin Oncol; 1993 Aug; 11(8):1523-8. PubMed ID: 8336190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
    Gucer F; Misirlioglu S; Ceydeli N; Taskiran C
    J Robot Surg; 2018 Mar; 12(1):49-58. PubMed ID: 28255734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase III double-blind randomized trial of radiation therapy for stage IIIb cervical cancer in combination with low- or high-dose Z-100: treatment with immunomodulator, more is not better.
    Noda K; Ohashi Y; Sugimori H; Ozaki M; Niibe H; Ogita S; Kohno I; Hasegawa K; Kikuchi Y; Takegawa Y; Fujii S; Tanaka K; Ochiai K; Kita M; Fujiwara K
    Gynecol Oncol; 2006 Jun; 101(3):455-63. PubMed ID: 16360199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
    Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose-rate intra-cavitary brachytherapy combined with external beam radiation therapy for under 40-year-old patients with invasive uterine cervical carcinoma: clinical outcomes in 118 Patients in a Japanese multi-institutional study, JASTRO.
    Yamashita H; Niibe Y; Toita T; Kazumoto T; Nishimura T; Kodaira T; Eto H; Kinoshita R; Tsujino K; Onishi H; Takemoto M; Hayakawa K
    Jpn J Clin Oncol; 2013 May; 43(5):547-52. PubMed ID: 23475536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study.
    Hernandez E; Donohue KA; Anderson LL; Heller PB; Stehman FB
    Gynecol Oncol; 2000 Aug; 78(2):137-42. PubMed ID: 10926792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
    Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
    Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.
    Dobrowsky W; Huigol NG; Jayatilake RS; Kizilbash NI; Okkan S; Kagiya VT; Tatsuzaki H
    Radiother Oncol; 2007 Jan; 82(1):24-9. PubMed ID: 17161478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy of alternating chemoradiotherapy by conformal radiotherapy combined with intracavitary brachytherapy for high-risk cervical cancer.
    Hirata K; Kodaira T; Tomita N; Ohshima Y; Ito J; Tachibana H; Nakanishi T; Fuwa N
    Jpn J Clin Oncol; 2014 Jun; 44(6):556-63. PubMed ID: 24755546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
    J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.